Trinity Biotech (TRIB) Assets Average (2009 - 2025)

Trinity Biotech's Assets Average history runs 17 years deep, the most recent figure standing at $102.4 million for Q4 2025.

• In Q4 2025, Assets Average rose 2.02% year-over-year to $102.4 million; the TTM figure through Dec 2025 stood at $102.4 million (up 2.02% YoY), while the FY2025 annual figure was $104.2 million, up 28.1% from the prior year.
• Assets Average came in at $102.4 million for Q4 2025 at Trinity Biotech, up from $101.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $133.2 million in Q1 2021 to a low of $61.5 million in Q4 2023.
• A 5-year average of $99.7 million and a median of $100.9 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average slumped 35.25% in 2023 and jumped 63.16% in 2024, its largest moves.
• Trinity Biotech's Assets Average stood at $120.8 million in 2021, then declined by 21.38% to $95.0 million in 2022, then sank by 35.25% to $61.5 million in 2023, then jumped by 63.16% to $100.4 million in 2024, then gained by 2.02% to $102.4 million in 2025.
• According to Business Quant data, Assets Average over the past three periods registered $102.4 million, $101.5 million, and $100.4 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison